Showing results (431-440 of 566) with videos related to
Sort By:
Pageof 57
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.Medical and Pediatric Oncology. Supplement|January 1, 1992
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell countsP Valent, C Sillaber, K Geissler, et al.Haematology and Blood Transfusion|January 1, 1990
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemiaB Clarkson, J Gaynor, C Little, et al.The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.Blood|September 15, 1996
A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemiaR Munker, T Kobayashi, E Elstner, et al.The American Journal of Medicine|April 29, 1998
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemiaM DeLima, M Albitar, S O'Brien, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activityL C Pagliaro, B Liu, R Munker, et al.International Journal of Oncology|August 3, 2007
Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stressB Ardelt, G Juan, P Burfeind, et al.Cancer Research|April 1, 1994
Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alphaJ Drach, T McQueen, H Engel, et al.Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.Pageof 57